Shattuck Labs Inc (STTK) earnings · next report Nov 5, 2026
Next report
Thu, Nov 5, 2026
Time not announced · Tomorrow
Quarter ended Sep 2026
- EPS consensus
- −$0.10 Range −$0.16 – −$0.0811 analystsYear ago −$0.14
- Revenue consensus
- $37.50K Range $0 – $300.00K8 analysts
EPS estimate trend
- 90 days ago−$0.12
- 60 days ago−$0.11
- 30 days ago−$0.11
- 7 days ago−$0.11
- Now−$0.11
Consensus +9.2% over 90 days. Last 30 days: 1 up, 1 down revisions.
Date and consensus: EODHD earnings calendar and estimates, refreshed every 6 hours. “Confirmed” means the provider lists the report session, which it sets once the company announces; “Estimated” is the provider’s expected date.
Follow STTK into its report
Save it to a free watchlist (no card). Alerts when the date moves or results land are part of Pro.
Earnings move
- Options price in (Nov 5)
- — No options snapshot for this report yet (taken daily in the 7 days before a report, for stocks with listed options).
- Average move after earnings
- ±3.4% Absolute close-to-close move, 2 reports
Options-implied move: the at-the-money straddle (call + put) on the first expiry after the report, divided by the stock’s close, from EODHD end-of-day option chains. It is what the options market prices as the absolute move to that expiry, not a forecast of direction. Move: close before the news → close after it (before the open: prior close → report-day close; after the close: report-day close → next close), adjusted for splits and dividends, from EODHD end-of-day prices. Reports with an unannounced time are not averaged: both candidate moves are stored instead. Per-report moves, gaps, moves vs SPY and the sector, beat/miss asymmetry and implied vs actual are in Lician Pro below.
Latest result
EPSGAAP
−$0.12
vs −$0.14 est. +14.3%
GAAP diluted EPS, SEC 10-Q
Revenue
$0
No revenue consensus stored
As filed with the SEC
EPS actuals are checked against the SEC filing and the company’s earnings press release (8-K EX-99.1). A company that reports only GAAP EPS is graded on its SEC diluted EPS; one that reports adjusted EPS is graded on the provider’s adjusted figure when the release confirms it. A figure that matches neither is shown as unverified, with no beat or miss. Revenue actuals come from the SEC filing of the same quarter where we have it.
Beat / miss history
- Beat EPS in 2 of 4
- Aug 11, 2026BeatEPS −$0.12GAAP vs −$0.14 +14.3%Rev $0 vs —
- May 7, 2026In lineEPS −$0.13GAAP vs −$0.13 0.0%Rev $0 vs —
- Nov 6, 2025BeatEPS −$0.14GAAP vs −$0.15 +6.7%Rev $1.00M vs —
- Aug 14, 2025In lineEPS −$0.24GAAP vs −$0.24 0.0%Rev $0 vs —
| Reported | Quarter | EPS est. | EPS actual | Surprise | Revenue est. | Revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Jun 2026 | −$0.14 | −$0.12GAAP | +14.3% | — | $0SEC | — |
| May 7, 2026 | Mar 2026 | −$0.13 | −$0.13GAAP | 0.0% | — | $0SEC | — |
| Nov 6, 2025 | Sep 2025 | −$0.15 | −$0.14GAAP | +6.7% | — | $1.00MSEC | — |
| Aug 14, 2025 | Jun 2025 | −$0.24 | −$0.24GAAP | 0.0% | — | $0SEC | — |
Earnings documents
- Earnings press releaseEX-99.1 · 8-K filed Aug 11, 2026Open on SEC.gov
Read the filing on LicianEDGAR filing index
Documents link to SEC EDGAR. Lician does not publish earnings-call transcripts.
Healthcare peers with similar quant ratings
STTK is rated 1.93 of 5 among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works
- ZLAB earnings1.96 · Sell · stock
- LRMR earnings1.95 · Sell · stock
- NKTR earnings1.94 · Sell · stock
- XRAY earnings1.94 · Sell · stock
- ABSI earnings1.92 · Sell · stock
- MPLT earnings1.91 · Sell · stock
- TMCI earnings1.91 · Sell · stock
- ELVN earnings1.90 · Sell · stock
| Quarter | Revenue | EPS | YoY |
|---|---|---|---|
| Q2 FY26 | — | −$0.12 | — |
| Q1 FY26 | — | −$0.13 | — |
| Q3 FY25 | $1.00M | −$0.14 | −66.6% |
| Q2 FY25 | — | −$0.24 | — |
Shattuck Labs Inc (STTK) is a biotechnology company listed on US.
Latest reported STTK revenue for 2025-12-31 was $1.0M. Net income was -$48.8M. Revenue was down 82.5% from 2024-12-31 to 2025-12-31. STTK currently screens at market cap $351.2M.
When the next STTK 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 82.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full STTK research stays on the stock page; the tape stays on the quote page.
STTK earnings FAQ
When is STTK's next earnings date?
Shattuck Labs Inc (STTK) is expected to report on Thu, Nov 5, 2026. This is the provider’s estimated date; the company has not confirmed it. Consensus EPS is −$0.10.
Did STTK beat earnings estimates last quarter?
Yes. On Aug 11, 2026 Shattuck Labs Inc (STTK) reported adjusted EPS of −$0.12 against a −$0.14 consensus (+14.3%), a beat.
How often does STTK beat EPS estimates?
Shattuck Labs Inc (STTK) beat the EPS consensus in 6 of its last 9 reported quarters.
What are STTK's latest revenue and net income?
Latest cached Shattuck Labs Inc (STTK) revenue for Dec 31, 2025 was $1.0M. Net income was -$48.8M. Statements: https://lician.com/financials/sttk
What is STTK's latest diluted EPS?
Latest cached Shattuck Labs Inc (STTK) diluted EPS for Dec 31, 2025 was -$0.70.
What period does the latest STTK earnings print cover?
The latest cached Shattuck Labs Inc (STTK) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did STTK revenue change from the prior cached period?
Cached Shattuck Labs Inc (STTK) revenue was down 82.5% from $5.7M (Dec 31, 2024) to $1.0M (Dec 31, 2025). Statements: https://lician.com/financials/sttk
Where are STTK earnings listed?
Cached earnings facts for Shattuck Labs Inc (STTK) are listed at https://lician.com/earnings/sttk. Statements: https://lician.com/financials/sttk
Not investment advice.